clinicians preference when semaglutide is not suitable Semaglutide, a GLP-1R agonist, also effective for MASH patients – MedNess Frontiers | Adverse events in

By dampening dopamine-driven impulsivity around eating, Wegovy can help reduce cravings for sugar, refined carbohydrates, and calorie dense snacks

This is essentially the same as the kitchen counter scenario

If you missed a dose by fewer than 5 days, simply take it when you remember and resume your regular schedule

Tirzepatide may offer more significant weight loss and improved glucose control compared to semaglutide, as it targets both GIP and GLP-1 receptors

p = 0.10), indicating that switching medications did not result in a significant reduction in HbA1c levels (Figure 13)

The Wegovy injection requires refrigeration , while the oral formulation does not